Medicortex Finland Oy 

Medicortex is developing biomarker diagnostics for rapid detection of concussion and mild traumatic brain injury (mTBI)

OWNER

Adrian Harel (See Profile)

Sector

Diagnostics

Stage

Prototyping, preclinical

Country

Finland

Medicortex kit uses non-invasive sample of urine or saliva for detection of concussion and mTBI.

The kit is useful both for professional and lay use.

Three pending patents protect our glycan-based biomarker technology.

The market potential is huge - estimated to be more than $2 billion.

This information is confidential, do not share or copy.

Under evaluation at least till: 24th of January

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

    ©2019 BioExpert Network

    About cookies

    This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

    If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

    ACEPTAR
    Aviso de cookies

    Log in with your credentials

    or    

    Forgot your details?

    Create Account

    Skip to toolbar